Half of COPD Patients Were Misdiagnosed as Having Asthma

June 8, 2006 - COPD (chronic obstructive pulmonary disease) - a progressive condition that leads to a worsening of respiratory symptoms, a decline in lung function and increased disability - tends to be under-diagnosed and under-treated. More than half of patients with COPD, for example, may be misdiagnosed as having asthma. Estimates are that almost three-fourths of COPD patients are senior citizens.

	Related Stories
	Help for Seniors on Chronic Obstructive Pulmonary Disease Posted on Web National Institutes of Health continues to build NIHSeniorHealth.gov Jan. 30, 2006 – The Website produced by the National Institutes of Health (NIH) to provide useful information on health specifically for seniors citizens continues to increase its content. Today, NIHSeniorHealth.gov adds information about the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the U.S. Read more... Read more on Health & Medicine

The new study results, published in the Journal of Asthma, are from the most recent prospective, patient-reported, objectively documented COPD study to examine COPD misdiagnosis.

COPD, which includes chronic bronchitis and emphysema, is characterized by a loss of lung function over time.⁽²⁾ Primarily a disease of current and former smokers, COPD affects nearly 12 million Americans.⁽³⁾ Unlike asthma, COPD is associated with a cascade of decline that leads to a diminished quality of life over time.⁽⁷⁾

Most people with COPD are at least 40 years old or around middle age when symptoms start. It is unusual, but possible, for people younger than 40 years of age to have COPD.

"Millions of people live with COPD for years, so their inability to do the things they enjoy because they simply can't breathe is devastating," said the study's lead author, David G. Tinkelman, M.D., Vice President for Health Initiatives, National Jewish Medical and Research Center, Denver.

"We need to clarify the differences between COPD and asthma so patients get the right diagnosis early and the appropriate interventions needed to change the course of this growing health crisis."

The study, conducted in Denver and Aberdeen, Scotland, and sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc, analyzed data from 597 patients age 40 and older with a history of lung disease or recent treatment with respiratory medications.⁽¹⁾ Patients were then screened using spirometry, a lung function test, to confirm their diagnosis of COPD.⁽¹⁾

In this study, a COPD diagnosis was defined in agreement with American Thoracic Society and European Respiratory Society guidelines as the presence of obstruction -- inability to get air out of the lungs -- based on spirometry results.⁽¹⁾

Of the 235 patients diagnosed with COPD by spirometry (measuring the capacity of the lungs), 51.5 percent reported a prior diagnosis of asthma only.⁽¹⁾ Only 37.9 percent of participants diagnosed with COPD based on the study tests reported a previous diagnosis of the disease,⁽¹⁾ while 10.6 percent reported no prior diagnosis of COPD or asthma.⁽¹⁾

"These findings are surprising given the availability of credible diagnosis and treatment guidelines specifically for COPD," noted Dr. Tinkelman. "Only through proper diagnosis and treatment will COPD patients fully benefit. Patients can benefit from lifestyle modifications, pulmonary rehabilitation and proper pharmacotherapy that may help them breathe better and return to the activities they enjoy."

About COPD

COPD is second-leading cause of disability⁽⁵⁾ and the fourth-leading cause of death in the U.S.⁽²⁾ While COPD is primarily caused by cigarette smoking, other causes of COPD include exposure to occupational dusts and chemicals.⁽²⁾ Researchers have also found a link between COPD and a rare genetic disorder involving a deficiency in the enzyme alpha1-antitrypsin (AAT) that normally prevents loss of elasticity in the lungs' fibers.⁽⁷⁾

The most common COPD symptoms include shortness of breath, chronic cough (sometimes with phlegm), and wheezing.⁽²⁾ In mild COPD, patients experience breathlessness during high-energy activities, such as exercise.⁽⁴⁾ As the disease worsens to the moderate and severe stages, patients become breathless more frequently, avoiding activities that cause shortness of breath.⁽⁴⁾ This can lead to physical deconditioning -- loss of muscle strength -- and disability.⁽⁴⁾ Patients eventually become breathless, even at rest.

COPD accounts for a high proportion of health-care costs -- nearly $40 billion in the U.S.⁽⁸⁾ In the last 20 years, COPD was also responsible for nearly 50 million hospital visits nationwide.⁽⁹⁾

COPD is, however, a manageable disease.⁽⁷⁾ According to diagnosis and treatment guidelines set by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), intervention can help improve and prevent some of the symptoms of COPD and improve health status and patient outcomes.⁽⁷⁾

About National Jewish Medical and Research Center

National Jewish Medical and Research Center is the only medical and research center in the United States devoted entirely to respiratory, allergic and immune system diseases, including asthma, tuberculosis, emphysema, severe allergies, lupus and other autoimmune diseases. Founded in 1899, this nonprofit and nonsectarian institution is dedicated to enhancing prevention, treatment and cures through research, and to developing and providing innovative clinical programs for treating patients regardless of age, religion, race or ability to pay. Website - http://www.njc.org/.

References:

⁽¹⁾ Tinkelman DG, Price D, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. Journal of Asthma. 43:1-6. 2006.

⁽²⁾ National Heart, Lung, and Blood Institute. Data Fact Sheet: ChronicObstructive Pulmonary Disease (COPD).Available at http://www.nhlbi.nih.gov/health/public/lung/other/copd_fact.pdf.Accessed June 25, 2004.

⁽³⁾ Centers for Disease Control. Summary health statistics for U.S.adults: National Health Interview Survey, 2003.National Center for Health Statistics. Vital Health Stat 10(225).2005. Table 3. Available at: http://www.cdc.gov/nchs/data/series/sr_10/sr10_225.pdf.

⁽⁴⁾ National Heart, Lung, and Blood Institute. Education StrategyDevelopment Workshop: Chronic Obstructive Pulmonary Disease. U.S.Department of Health and Human Services. December 2005.

⁽⁵⁾ Beers MH, ed. The Merck Manual-Second Home Edition. Chronicobstructive pulmonary disease. Available at: http://www.merck.com/mmhe/sec04/ch045/ch045a.html.

⁽⁷⁾ Global Initiative for Chronic Obstructive Lung Disease. GlobalStrategy for the Diagnosis, Management andPrevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHOworkshop report. Bethesda, National Heart, Lung and Blood Institute,April 2001; Updated September 2005. Available at http://www.goldcopd.com.

⁽⁸⁾ National Institutes of Health. NHLBI Morbidity & Mortality: 2004 ChartBook on Cardiovascular, Lung * Blood Diseases. May 2004. Available at: http://www.nhlbi.nih.gov/resources/docs/cht-book.htm.

⁽⁹⁾ Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality inCOPD-related Hospitalizations in the United States, 1979-2001*. Chest,October 2005. 2005-2011.

(10) National Health Interview Survey

SOURCE: National Jewish Medical and Research Center

Click to More Senior News on the Front Page

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, www.DeweySquare.com, SASeniors.com, DrugDanger.com, etc.

E-mail - editor@SeniorJournal.com